Alliance Pharma (LSE:APH) Days Sales Outstanding : 90.83 (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Days Sales Outstanding?

Alliance Pharma's average Accounts Receivable for the six months ended in Jun. 2023 was £40.5 Mil. Alliance Pharma's Revenue for the six months ended in Jun. 2023 was £81.4 Mil. Hence, Alliance Pharma's Days Sales Outstanding for the six months ended in Jun. 2023 was 90.83.

The historical rank and industry rank for Alliance Pharma's Days Sales Outstanding or its related term are showing as below:

LSE:APH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.87 Med: 63.35 Max: 86.2
Current: 86.2

During the past 13 years, Alliance Pharma's highest Days Sales Outstanding was 86.20. The lowest was 54.87. And the median was 63.35.

LSE:APH's Days Sales Outstanding is ranked worse than
65.23% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs LSE:APH: 86.20

Alliance Pharma's Days Sales Outstanding increased from Jun. 2022 (81.42) to Jun. 2023 (90.83).

Alliance Pharma Days Sales Outstanding Historical Data

The historical data trend for Alliance Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Days Sales Outstanding Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

62.92

63.77

61.61

56.64

82.40

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															56.84	64.70	81.42	86.69	90.83

Competitive Comparison of Alliance Pharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alliance Pharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's Days Sales Outstanding falls into.

Alliance Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Alliance Pharma's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (30.821	+	44.764)	/	2 )	/	167.416	*	365
=	37.7925					/	167.416	*	365
=	82.40

Alliance Pharma's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (44.764	+	36.259)	/	2 )	/	81.398	*	365 / 2
=	40.5115					/	81.398	*	365 / 2
=	90.83

Alliance Pharma (LSE:APH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Alliance Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).